Tenpoint Therapeutics has raised £54 million Series A funding to develop breakthrough regenerative treatments for eye diseases. The company is based on the work of its scientific founders from Moorfields Eye Hospital, the UCL Institute of Ophthalmology, Institut de la Vision and the University of Washington. It is developing a series of ex vivo and … Continue reading £54m to help MedTech fight degenerative eye diseases